免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

Reliability and Performance Analysis of the Use of Tissue Flossing for Blood Flow Restriction.

NCT:NCT06075901 · ENROLLING_BY_INVITATION

NCT编号NCT06075901
状态ENROLLING_BY_INVITATION
开始日期2025-08-01
SponsorPaulista University (OTHER)
First posted
Last updated

简要摘要

Blood flow restriction (RFS) is a widely studied technique that combines low-intensity exercise with vascular occlusion, resulting in muscular benefits. However, its application is challenging due to methodological variations and equipment costs. Tissue Flossing (TF) appears as an affordable alternative, but lacks solid scientific evidence.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑